Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity

Cancer

Volumn 82, Issue 2, 1998, Pages 252-260

  Saussez, Sven ^a   Marchant, Hadelin ^b   Nagy, Nathalie ^a   Decaestecker, Christine ^c   Hassid, Sergio ^a   Jortay, Albert ^b   Schüring, Max Peter ^d   Gabius, Hans Joachim ^d   Danguy, André ^c   Salmon, Isabelle ^a   Kiss, Robert ^c,e,f  

^a ERASME HOSPITAL   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF MUNICH   (Germany)

^e FNRS   (Belgium)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Cancer; Computer assisted microscopy; Lectins; Oral cavity; Prognosia; Quantitative measurements

Indexed keywords

LECTIN; NEOGLYCOPROTEIN; PEANUT AGGLUTININ; SARCOLECTIN; THOMSEN FRIEDENREICH ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROSCOPY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; COLORING AGENTS; COMPUTER SYSTEMS; DISCRIMINANT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCYTOCHEMISTRY; HUMANS; ISOANTIGENS; LECTINS; MALE; MICROSCOPY; MIDDLE AGED; MOUTH NEOPLASMS; MUSCLE PROTEINS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PEANUT AGGLUTININ; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031985933     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980115)82:2<252::AID-CNCR2>3.0.CO;2-T     Document Type: Article

References (30)

1. Schantz SP, Harrison LB, Hong WK. Cancer of the head and neck. Section 1. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita VT Jr., Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 4th edition. Philadelphia: J. B. Lippincott, 1993:574-630.
2. Menck HR, Garfinkel L, Dodd GD. Preliminary report of the National Cancer Data Base. CA Cancer J Clin 1991;41:7-39.
3. Foote RL, Schild SE, Thompson WM, Buskirk SJ, Olsen KD, Stanley RJ, et al. Tonsil cancer: patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer 1994;73:2638-47.
4. Kroll SO, Hoffman S. Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients. J Am Dent Assoc 1976;92:571-4.
5. Bloom NO, Spiro RH. Carcinoma of the cheek mucosa: a retrospective analysis. Am J Surg 1980;140:556-9.
6. American Joint Committee on Cancer. Manual for staging of cancer. 3rd edition. Philadelphia: J. B. Lippincott, 1988:217.
7. Freije SA, Mostofi RS, Bostwick DG. Alterations in glycoconjugate expression following transformation of human oropharyngeal squamous mucosa. Laryngoscope 1989;99:197-203.
8. Saku T, Okabe H. Differential lectin-bindings in normal and precancerous epithelium and squamous cell carcinoma of the oral mucosa. J Oral Pathol Med 1989;18:438-45.
9. Feinmesser R, Freeman JL, Noyek A, Van Nostrand P. Lectin binding characteristics of laryngeal cancer. Otolaryngol Head Neck Surg 1989;100:207-9.
10. Lalwani AK, Carey TE, Goldstein IJ, Peters BP. Lectin binding characteristics of squamous cell carcinomas of the head and neck. Acta Otolaryngol 1996;116:125-31.
11. Dabelsteen E, Pindborg JJ. Loss of epithelial blood group substance A in oral carcinomas. Acta Pathol Microbiol Scand (A) 1973;81:435-44.
12. Lin F, Liu PI, McGregor DH. Isoantigens A, B, and H in morphologically normal mucosa and in carcinoma of the larynx. Am J Clin Pathol 1977;68:372-6.
13. Dabelsteen E, Vedtofte P, Hakomori S, Young WW Jr. Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res 1983;43:1451-4.
14. Carey TE, Wolf GT, Hsu S, Poore J, Peterson K, McClatchey KD. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma. Otolaryngol Head Neck Surg 1987;96:221-30.
15. Bryne M, Thrane PS, Dabelsteen E. Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas. Cancer 1990;66:2118-23.
16. Bryne M, Reidel J, Mandel U, Dabelsteen E. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions. J Oral Pathol Med 1991;20:120-5.
17. Gabius HJ, Schröter C, Gabius S, Brinck U, Tietze LF. Binding of T-antigen-bearing neoglycoprotein and peanut agglutinin to cultured tumor cells and breast carcinomas. J Histochem Cytochem 1990;38:1625-31.
18. Chany-Fournier F, Jiang PH, Chany C. Sarcolectin and interferon in the regulation of cell growth. J Cell Physiol 1990;145: 173-80.
19. Zeng FY, Gerke V, Gabius HJ. Characterization of the macrophage migration inhibitory factor-binding site of sarcolectin and its relationship to human serum albumin. Biochem Biophys Res Commun 1994;200:89-94.
20. Kayser K, Bovin NV, Korxchagina EY, Zeilinger C, Zeng FY, Gabius HJ. Correlation of expression of binding sites for the synthetic blood group A-, B-, and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer 1994;30A:653-7.
21. Hyams VJ, Batsakis JG, Michaels L, editors. Tumors of the upper respiratory tract and ear. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1988.
22. Gabius HJ, Gabius S, editors. Glycosciences: status and perspectives. London: Chapman and Hall, 1997.
23. Jannot MC, Kruczynski A, Limouzy A, Dangou JM, Selves J, Delsol G, et al. Spontaneous evolution of cytoplasmic lectin binding and nuclear size and deoxyribonucleic acid content in human colorectal cancers grafted onto nude mice. Lab Invest 1993;68:446-55.
24. Remmelink M, Salmon I, Goldschmidt D, Decaestecker C, Nemec E, Berthe JV, et al. Quantitative measurements of desmin and vimentin immunostains and cell density in leiomyomas and leiomyosarcomas. Anal Cell Pathol 1996; 12:25-44.
25. Goldschmidt D, Decaestecker C, Berthe JV, Gordower L, Remmelink M, Danguy A, et al. The contribution of computer-assisted methods for histopathological classification of adipose tumors. Lab Invest 1996;75:295-306.
26. Johnson RA, Wicheren DW. Applied multivariate statistical analysis. 3rd edition. Englewood Cliffs: Prentice-Hall International Editions, 1992.
27. McLachlan GJ, Discriminant analysis and statistical pattern recognition. New York: John Wiley & Sons, Inc., 1992.
28. Bryne M. Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. J Oral Pathol Med 1991;20:413-20.
29. Irimura T, Nakajima M, Yamori T, Ota DM, Cleary KF, Nicolson GL. Glycoconjugates and tumor metastasis. Adv Exp Med Biol 1988;228:677-703.
30. Miyake M, Hakomoti S. A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 1991;30:3328-34.